TBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TrueBlue Inc (TBI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts such as insider buying and improved financial metrics, the lack of strong trading signals, mixed technical indicators, and the company's negative net income suggest that it is better to hold off on investing in this stock right now.
The MACD histogram is positive at 0.0387, indicating a bullish trend, but it is contracting. RSI is neutral at 30.189, and moving averages are converging, showing no clear direction. The stock is trading near support levels (S1: 3.329) but far from resistance levels (R1: 4.108).
Insiders are buying heavily, with a 1035.89% increase in buying activity over the last month. Financials show YoY improvement in revenue (+8.35%), net income (+169.42%), and EPS (+162.50%).
No recent news or congress trading data to act as a catalyst. The stock has an 80% chance of declining by -1.52% in the next day.
For Q4 2025, revenue increased by 8.35% YoY to $418.18M. Net income improved significantly but remains negative at -$31.54M (+169.42% YoY). EPS also improved but is still negative at -1.05 (+162.50% YoY). Gross margin declined to 20.06%, down -19.79% YoY.
Baird maintains an Outperform rating but has lowered the price target from $7 to $5.50, reflecting a cautious outlook.
